CD Formulation, a leading provider of analytical and formulation services, has recently announced the launch of its new Genotoxic Impurity (GI) Testing services. This innovative offering aims to ...
A global recall may get expanded beyond valsartan as regulators continue to find potentially cancer-causing impurities in other “sartan” products. European regulators say they have found the same ...
Discovery of the allosteric inhibitor from actinomyces metabolites to target EGFR CSTMLR mutant protein: molecular modeling and free energy approach Seven commercial samples from different origins ...
Mylan recalls three lots of nizatidine capsules, USP, due to detection of NDMA impurity found in API
Mylan N.V. announced that its US based Mylan Pharmaceuticals business is conducting a voluntary nationwide recall, to the consumer level, of three lots of nizatidine capsules, USP (including the 150mg ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results